Literature DB >> 20023683

Is angiotensin system blockade indicated in the elderly?

Carolyn Bauer, Matthew Abramowitz, Thomas H Hostetter.   

Abstract

Mesh：

Substances：

Year:  2010        PMID： 20023683     DOI： 10.1038/nrneph.2009.206

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN： 1759-5061            Impact factor:   28.314


× No keyword cloud information.
  10 in total

1.  K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease.

Authors: 
Journal:  Am J Kidney Dis       Date:  2004-05       Impact factor: 8.860

2.  A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group.

Authors:  A S Levey; J P Bosch; J B Lewis; T Greene; N Rogers; D Roth
Journal:  Ann Intern Med       Date:  1999-03-16       Impact factor: 25.391

3.  Efficacy and safety of angiotensin II receptor blockade in elderly patients with diabetes.

Authors:  Wolfgang C Winkelmayer; Zhongxin Zhang; Shahnaz Shahinfar; Mark E Cooper; Jerry Avorn; Barry M Brenner
Journal:  Diabetes Care       Date:  2006-10       Impact factor: 19.112

4.  Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

Authors:  Mahboob Rahman; Sara Pressel; Barry R Davis; Chuke Nwachuku; Jackson T Wright; Paul K Whelton; Joshua Barzilay; Vecihi Batuman; John H Eckfeldt; Michael Farber; Mario Henriquez; Nelson Kopyt; Gail T Louis; Mohammad Saklayen; Carol Stanford; Candace Walworth; Harry Ward; Thomas Wiegmann
Journal:  Arch Intern Med       Date:  2005-04-25

5.  Prevalence of chronic kidney disease in the United States.

Authors:  Josef Coresh; Elizabeth Selvin; Lesley A Stevens; Jane Manzi; John W Kusek; Paul Eggers; Frederick Van Lente; Andrew S Levey
Journal:  JAMA       Date:  2007-11-07       Impact factor: 56.272

6.  Current guidelines for using angiotensin-converting enzyme inhibitors and angiotensin II-receptor antagonists in chronic kidney disease: is the evidence base relevant to older adults?

Authors:  Ann M O'Hare; James S Kaufman; Kenneth E Covinsky; C Seth Landefeld; Lynne V McFarland; Eric B Larson
Journal:  Ann Intern Med       Date:  2009-05-19       Impact factor: 25.391

7.  Effect of telmisartan on renal outcomes: a randomized trial.

Authors:  Johannes F E Mann; Roland E Schmieder; Leanne Dyal; Matthew J McQueen; Helmut Schumacher; Janice Pogue; Xingyu Wang; Jeffrey L Probstfield; Alvaro Avezum; Ernesto Cardona-Munoz; Gilles R Dagenais; Rafael Diaz; George Fodor; Jean M Maillon; Lars Rydén; Cheuk M Yu; Koon K Teo; Salim Yusuf
Journal:  Ann Intern Med       Date:  2009-05-18       Impact factor: 25.391

8.  Age affects outcomes in chronic kidney disease.

Authors:  Ann M O'Hare; Andy I Choi; Daniel Bertenthal; Peter Bacchetti; Amit X Garg; James S Kaufman; Louise C Walter; Kala M Mehta; Michael A Steinman; Michael Allon; William M McClellan; C Seth Landefeld
Journal:  J Am Soc Nephrol       Date:  2007-09-12       Impact factor: 10.121

9.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  JAMA       Date:  2003-05-14       Impact factor: 56.272

10.  Effects of ramipril and rosiglitazone on cardiovascular and renal outcomes in people with impaired glucose tolerance or impaired fasting glucose: results of the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) trial.

Authors:  G R Dagenais; H C Gerstein; R Holman; A Budaj; A Escalante; T Hedner; M Keltai; E Lonn; S McFarlane; M McQueen; K Teo; P Sheridan; J Bosch; J Pogue; S Yusuf
Journal:  Diabetes Care       Date:  2008-02-11       Impact factor: 19.112
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.